← FDA Drug Approvals (Drugs@FDA)
BETAMETHASONE DIPROPIONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TP ANDA HOLDINGS · Approved 2022-02-18
Drug application
- FDA Application #
ANDA215186- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BETAMETHASONE DIPROPIONATE
- Generic name
- BETAMETHASONE DIPROPIONATE USP, 0.05%
- Active ingredients
- BETAMETHASONE DIPROPIONATE
- Dosage form
- OINTMENT
- Route
- TOPICAL
- Marketing status
- Prescription
- Sponsor
- TP ANDA HOLDINGS
- Manufacturer
- TruPharma LLC
- First approval
- 2022-02-18
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown